Dexcom (DXCM) Non-Current Assets (2010 - 2026)
Dexcom (DXCM) posted quarterly Non-Current Assets of $2.4 billion for Q2 2026, up 3.13% year-over-year from $2.3 billion in Q2 2025, and up 2.92% quarter-over-quarter from $2.3 billion in Q1 2026.
Dexcom (DXCM) Non-Current Assets (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Non-Current Assets for 17 consecutive years, with $2.4 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets rose 3.13% year-over-year to $2.4 billion; the TTM figure through Jun 2026 stood at $9.3 billion (up 5.57% YoY), while the FY2025 annual figure was $2.3 billion, up 5.66% from the prior year.
- Non-Current Assets climbed to $2.4 billion in Q2 2026 per DXCM's latest filing, from $2.3 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $2.4 billion in Q2 2026 and bottomed at $1.3 billion in Q1 2022.
- Historically, Non-Current Assets has averaged $1.9 billion across 5 years, with a median of $1.9 billion in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 38.71% — and 2026, when it grew 3.13%.
- Dexcom's Non-Current Assets stood at $1.7 billion in 2022, then gained by 6.72% to $1.8 billion in 2023, then climbed by 18.74% to $2.2 billion in 2024, then advanced by 5.66% to $2.3 billion in 2025, then advanced by 2.69% to $2.4 billion in 2026.
- Business Quant data shows DXCM's Non-Current Assets at $2.4 billion in Q2 2026, $2.3 billion in Q1 2026, and $2.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 17.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.37 Bn |
| Mar 31, 2026 | 2.30 Bn |
| Dec 31, 2025 | 2.31 Bn |
| Sep 30, 2025 | 2.28 Bn |
| Jun 30, 2025 | 2.30 Bn |
| Mar 31, 2025 | 2.20 Bn |
| Dec 31, 2024 | 2.18 Bn |
| Sep 30, 2024 | 2.09 Bn |
| Jun 30, 2024 | 1.95 Bn |
| Mar 31, 2024 | 1.86 Bn |
| Dec 31, 2023 | 1.84 Bn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 1.82 Bn |
| Mar 31, 2023 | 1.75 Bn |
| Dec 31, 2022 | 1.72 Bn |
| Sep 30, 2022 | 1.50 Bn |
| Jun 30, 2022 | 1.41 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.25 Bn |
| Sep 30, 2021 | 1.12 Bn |